Moreover, a separate study of patients with RA receiving tumor necrosis factor inhibitors with or without MTX showed that the disease activity observed within the first 3 months of treatment was significantly related to disease activity at 1 year [9]. This evidence concerns the gene TNF and rheumatoid arthritis.